Javascript must be enabled to continue!
Sacral Insufficiency Fracture Mimicking Metastatic Prostate Cancer on 18F-PSMA-1007 PET/CT
View through CrossRef
Accurate diagnosis of sacral insufficiency fractures in oncology patients may be challenging. We describe 18F-PSMA-1007 PET/CT findings of sacral insufficiency fracture in a patient with a history of prostate cancer and pelvic radiotherapy. The insufficiency fracture in the left sacral ala showed no oblivious structural changes and diffuse heterogeneous activity with SUVmax of 7.7 on 18F-PSMA-1007 PET/CT mimicking metastatic prostate cancer. A follow-up 99mTc-MDP SPECT/CT showed progression of the insufficiency fracture from the left sacral ala to the right sacral ala. A low level of serum prostate-specific antigen may be helpful for the diagnosis.
Ovid Technologies (Wolters Kluwer Health)
Title: Sacral Insufficiency Fracture Mimicking Metastatic Prostate Cancer on 18F-PSMA-1007 PET/CT
Description:
Accurate diagnosis of sacral insufficiency fractures in oncology patients may be challenging.
We describe 18F-PSMA-1007 PET/CT findings of sacral insufficiency fracture in a patient with a history of prostate cancer and pelvic radiotherapy.
The insufficiency fracture in the left sacral ala showed no oblivious structural changes and diffuse heterogeneous activity with SUVmax of 7.
7 on 18F-PSMA-1007 PET/CT mimicking metastatic prostate cancer.
A follow-up 99mTc-MDP SPECT/CT showed progression of the insufficiency fracture from the left sacral ala to the right sacral ala.
A low level of serum prostate-specific antigen may be helpful for the diagnosis.
Related Results
68Ga-PSMA-11 PET/CT Imaging in Brain Gliomas and Its Correlation With Clinicopathological Prognostic Parameters
68Ga-PSMA-11 PET/CT Imaging in Brain Gliomas and Its Correlation With Clinicopathological Prognostic Parameters
Background
Gliomas are the most common primary central nervous system tumors, of which the malignant gliomas account for 60%–75%. The primary and secondary brain malign...
Bridging bones
Bridging bones
Chapter 2 presents the evaluation of the feasibility of utilizing whole-body [18F]Fluoride PET/CT for visualizing molecular new bone formation in clinically active PsA patients. Th...
SEMANA DE ENFERMAGEM E SEUS ASPECTOS SOCIAIS NA VALORIZAÇÃO PROFISSIONAL: UM RELATO DE EXPERIÊNCIA DO GRUPO PET-ENFERMAGEM
SEMANA DE ENFERMAGEM E SEUS ASPECTOS SOCIAIS NA VALORIZAÇÃO PROFISSIONAL: UM RELATO DE EXPERIÊNCIA DO GRUPO PET-ENFERMAGEM
A enfermagem é o pilar da assistência pois está na linha de frente do cuidado holístico, todavia esta é estigmatizada e desvalorizada, assim como não possui reconhecimento consider...
Detection Efficiency of 18F-PSMA-1007 PET/CT and Multi-parameter MRI in Prostate Cancer and Its Correlation with Pathological Grade
Detection Efficiency of 18F-PSMA-1007 PET/CT and Multi-parameter MRI in Prostate Cancer and Its Correlation with Pathological Grade
Motivation: The combination of MRI imaging and PSMA PET/CT imaging has attracted more and more attention. Goal(s): Therefore, this study will compare the diagnostic value of 18F-PS...
In situ Generated 212Pb-PSMA Ligand in a 224Ra-Solution for Dual Targeting of Prostate Cancer Sclerotic Stroma and PSMA-positive Cells
In situ Generated 212Pb-PSMA Ligand in a 224Ra-Solution for Dual Targeting of Prostate Cancer Sclerotic Stroma and PSMA-positive Cells
Background:
New treatments combating bone and extraskeletal metastases are needed for
patients with metastatic castration-resistant prostate cancer. The majority of metastases over...
Abstract 976: The regulation of FOLH1/PSMA in prostate cancer
Abstract 976: The regulation of FOLH1/PSMA in prostate cancer
Abstract
Prostate Specific Membrane Antigen (PSMA) is a prominent biomarker in Prostate Cancer (PC) and has evolved into a useful target for both imaging and therapy...
Diagnostic value of 18F-FDG PET/MRI for staging in patients with ovarian cancer
Diagnostic value of 18F-FDG PET/MRI for staging in patients with ovarian cancer
Abstract
Purpose: To evaluate the diagnostic potential of PET/MRI with 18F-fluorodeoxyglucose (18F-FDG) in ovarian cancer.Materials and Methods: Participants comprised 103 ...
How Reliable Is the High-Volume Definition in Prostate Cancer Patients: The Potential Game-Changing Role of PSMA
How Reliable Is the High-Volume Definition in Prostate Cancer Patients: The Potential Game-Changing Role of PSMA
Abstract
Purpose
To evaluate whether metabolic and volumetric data from Ga-68 PSMA PET CT performed during staging of denovo high-volume mCSPC patients who received doceta...

